Overview

• The DEA has scheduled a hearing for December 2 to discuss reclassifying marijuana.
• A final decision on the reclassification may not occur until the next presidential administration.
• Vice President Kamala Harris and former President Donald Trump have differing views on marijuana policy.
• Rescheduling could significantly impact federal drug policy, research, and the marijuana industry.
• Opposition groups argue there is insufficient data to support moving cannabis to a less restrictive category.